225 related articles for article (PubMed ID: 9607453)
1. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
Huang DT; Monahan KM; Zimetbaum P; Papageorgiou P; Epstein LM; Josephson ME
J Cardiovasc Electrophysiol; 1998 May; 9(5):462-9. PubMed ID: 9607453
[TBL] [Abstract][Full Text] [Related]
2. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
Tai CT; Chiang CE; Lee SH; Chen YJ; Yu WC; Feng AN; Ding YA; Chang MS; Chen SA
J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1180-7. PubMed ID: 10517649
[TBL] [Abstract][Full Text] [Related]
3. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
Nabar A; Rodriguez LM; Timmermans C; van Mechelen R; Wellens HJ
Heart; 2001 Apr; 85(4):424-9. PubMed ID: 11250970
[TBL] [Abstract][Full Text] [Related]
4. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
Reithmann C; Hoffmann E; Spitzlberger G; Dorwarth U; Gerth A; Remp T; Steinbeck G
Eur Heart J; 2000 Apr; 21(7):565-72. PubMed ID: 10775011
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
[TBL] [Abstract][Full Text] [Related]
6. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
7. [Atrial flutter and fibrillation].
Scharf C
Praxis (Bern 1994); 2005 Nov; 94(45):1753-9. PubMed ID: 16320889
[TBL] [Abstract][Full Text] [Related]
8. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
[TBL] [Abstract][Full Text] [Related]
10. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter.
De Bortoli A; Shi LB; Ohm OJ; Hoff PI; Schuster P; Solheim E; Chen J
Scand Cardiovasc J; 2017 Jun; 51(3):123-128. PubMed ID: 28335638
[TBL] [Abstract][Full Text] [Related]
13. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
[TBL] [Abstract][Full Text] [Related]
14. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
[TBL] [Abstract][Full Text] [Related]
15. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
[TBL] [Abstract][Full Text] [Related]
17. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
18. Circumferential pulmonary-vein ablation for chronic atrial fibrillation.
Oral H; Pappone C; Chugh A; Good E; Bogun F; Pelosi F; Bates ER; Lehmann MH; Vicedomini G; Augello G; Agricola E; Sala S; Santinelli V; Morady F
N Engl J Med; 2006 Mar; 354(9):934-41. PubMed ID: 16510747
[TBL] [Abstract][Full Text] [Related]
19. Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation.
Anastasio N; Frankel DS; Deyell MW; Zado E; Gerstenfeld EP; Dixit S; Cooper J; Lin D; Marchlinski FE; Callans DJ
J Interv Card Electrophysiol; 2012 Oct; 35(1):57-61. PubMed ID: 22552760
[TBL] [Abstract][Full Text] [Related]
20. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.
Ellis K; Wazni O; Marrouche N; Martin D; Gillinov M; McCarthy P; Saad EB; Bhargava M; Schweikert R; Saliba W; Bash D; Rossillo A; Erciyes D; Tchou P; Natale A
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):799-802. PubMed ID: 17593230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
